Date of Report (date of earliest event reported): 7/29/2025
___________________________________
The Procter & Gamble Company
(Exact name of registrant as specified in its charter)
___________________________________
Ohio
(State or other jurisdiction of
incorporation or organization)
001-00434
(Commission File Number)
31-0411980
(I.R.S. Employer Identification Number)
One Procter & Gamble Plaza
Cincinnati, Ohio45202
(Address of principal executive offices and zip code)
(513) 983-1100
(Registrant's telephone number, including area code)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock without Par Value
PG
NYSE
0.110% Notes due 2026
PG26D
NYSE
3.25% EUR Notes due 2026
PG26F
NYSE
4.875% EUR Notes due May 2027
PG27A
NYSE
1.200% Notes due 2028
PG28
NYSE
3.150% EUR Notes due 2028
PG28B
NYSE
1.250% Notes due 2029
PG29B
NYSE
1.800% Notes due 2029
PG29A
NYSE
6.250% GBP Notes due January 2030
PG30
NYSE
0.350% Notes due 2030
PG30C
NYSE
0.230% Notes due 2031
PG31A
NYSE
3.250% EUR Notes due 2031
PG31B
NYSE
5.250% GBP Notes due January 2033
PG33
NYSE
3.200% EUR Notes due 2034
PG34C
NYSE
1.875% Notes due 2038
PG38
NYSE
0.900% Notes due 2041
PG41
NYSE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01 - Regulation FD Disclosure
On July 29, 2025, The Procter & Gamble Company (the "Company") issued a press release announcing its fourth quarter and fiscal year 2025 results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website.
This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure."
Item 9.01 - Financial Statements and Exhibits
(d): The following exhibits are being filed herewith:
Exhibit No.
Description
99.1
Informational Slides Provided by The Procter & Gamble Company dated July 29, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 29th day of July, 2025.